MedTrace Logo

Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)

NCT00742794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2010-08-19

No results posted yet for this study

Summary

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Conditions

  • Hymenoptera Sting Allergy

Interventions

OTHER

Observation

Observation of sting frequency

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • 01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich

Eligibility

Min Age
5 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Completion
2010-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00742794 on ClinicalTrials.gov